Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation

This publication has 36 references indexed in Scilit:

• Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system
  Nature Immunology, 2006
• Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells
  Nature Immunology, 2006
• Potent Antitumor Activity of Interleukin-27
  Cancer Research, 2004
• IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL
  Blood, 2003
• Differential Expression of Gamma Interferon mRNA Induced by Attenuated and VirulentMycobacterium tuberculosisin Guinea Pig Cells afterMycobacterium bovisBCG Vaccination
  Infection and Immunity, 2003
• The Loss of Smad3 Results in a Lower Rate of Bone Formation and Osteopenia Through Dysregulation of Osteoblast Differentiation and Apoptosis
  Journal of Bone and Mineral Research, 2001
• Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-κB Ligand: Modulation of the Expression by Osteotropic Factors and Cytokines
  Biochemical and Biophysical Research Communications, 2000
• STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone
  Journal of Biological Chemistry, 1999
• IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
  Journal of Clinical Investigation, 1999
• Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway
  Cell, 1996